We use cookies for a better user experience. Read our Privacy Policy
I AgreeTo know the scope of our report Get a Sample on Diagnostic Specialty Antibodies Market?
Get a glimpse of the in-depth analysis through our Report Brochure
Expanding operations in future? To get the perfect launch ask for a custom report
High unmet needs in the global diagnostic specialty antibody market present lucrative opportunities for existing players and new entrants. For instance, Abcam plc plans to strengthen its position in Asia, specifically in China, to increase market share in unpenetrated segments and offer custom products and licensing. Additionally, in November 2016, Roche launched the global cancer immunotherapy Centers of Research Excellence (imCORE) network which brings together world’s leading scientific and clinical experts in cancer immunotherapy to collaborate in investigating promising new treatment approaches. The company announced investment up to CHF 100 Mn (US$ 98 Mn) to support basic and clinical research collaborations related to cancer immunotherapy.
The report on the global diagnostic specialty antibody market discusses individual strategies followed by company profiles of manufacturers of diagnostic specialty antibody treatment products. The competitive landscape section has been included in the diagnostic specialty antibody market report to provide readers with a dashboard view and a company diagnostic specialty antibody market share analysis of key players operating in the global diagnostic specialty antibody market.
The global diagnostic specialty antibodies market has been segmented as follows:
Antibody Type |
|
Application |
|
End-user |
|
Region |
|
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
Diagnostic specialty antibodies market was valued at US$ 22.6 Bn in 2018 and to reach US$ 35.8 Bn by 2027
Diagnostic specialty antibodies market is anticipated to expand at a CAGR of 5.3% from 2019 to 2027
Diagnostic specialty antibodies market is driven by increase in demand for accurate and prompt diagnosis of various diseases across the globe
North America held the largest share of the global diagnostic specialty antibody market, and this region is projected to grow at a rapid pace during the forecast period
Key players in the global diagnostic specialty antibody market include F. Hoffmann-La Roche AG, Sanofi, and Abbott Laboratories, Abcam plc, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diagnostic Specialty Antibody Market
4. Market Overview
4.1. Introduction
4.1.1. Antibody Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diagnostic Specialty Antibody Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Disease Prevalence & Incidence Rate globally with key countries / Region
5.2. Pipeline Analysis
5.3. Key Industry Developments
6. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by Antibody Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Antibody Type, 2017–2027
6.3.1. Monoclonal Antibodies
6.3.2. Polyclonal Antibodies
6.3.3. Recombinant Polyclonal Antibodies
6.4. Market Attractiveness, by Antibody Type
7. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2027
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2027
8.3.1. Hepatitis Diagnosis
8.3.2. Tuberculosis Diagnostics
8.3.3. Dengue Diagnostics
8.3.4. Oncology Diagnostics
8.3.5. HIV Diagnostics
8.3.6. Infectious Disease Diagnostics
8.3.7. Others Diagnostics
8.4. Market Attractiveness Analysis, by Application
9. Global Diagnostic Specialty Antibody Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Diagnostic Specialty Antibody Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Antibody Type, 2017–2027
10.2.1. Monoclonal Antibodies
10.2.2. Polyclonal Antibodies
10.2.3. Recombinant Polyclonal Antibodies
10.3. Market Value Forecast, by End-user, 2017–2027
10.3.1. Hospitals
10.3.2. Diagnostic Laboratories
10.3.3. Others
10.4. Market Value Forecast, by Application, 2017–2027
10.4.1. Hepatitis Diagnosis
10.4.2. Tuberculosis Diagnostics
10.4.3. Dengue Diagnostics
10.4.4. Oncology Diagnostics
10.4.5. HIV Diagnostics
10.4.6. Infectious Disease Diagnostics
10.4.7. Others Diagnostics
10.5. Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Antibody Type
10.6.2. By End-user
10.6.3. By Application
10.6.4. By Country
11. Europe Diagnostic Specialty Antibody Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Antibody Type, 2017–2027
11.2.1. Monoclonal Antibodies
11.2.2. Polyclonal Antibodies
11.2.3. Recombinant Polyclonal Antibodies
11.3. Market Value Forecast, by End-user, 2017–2027
11.3.1. Hospitals
11.3.2. Diagnostic Laboratories
11.3.3. Others
11.4. Market Value Forecast, by Application, 2017–2027
11.4.1. Hepatitis Diagnosis
11.4.2. Tuberculosis Diagnostics
11.4.3. Dengue Diagnostics
11.4.4. Oncology Diagnostics
11.4.5. HIV Diagnostics
11.4.6. Infectious Disease Diagnostics
11.4.7. Others Diagnostics
11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Antibody Type
11.6.2. By End-user
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Diagnostic Specialty Antibody Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Antibody Type, 2017–2027
12.2.1. Monoclonal Antibodies
12.2.2. Polyclonal Antibodies
12.2.3. Recombinant Polyclonal Antibodies
12.3. Market Value Forecast, by End-user, 2017–2027
12.3.1. Hospitals
12.3.2. Diagnostic Laboratories
12.3.3. Others
12.4. Market Value Forecast, by Application, 2017–2027
12.4.1. Hepatitis Diagnosis
12.4.2. Tuberculosis Diagnostics
12.4.3. Dengue Diagnostics
12.4.4. Oncology Diagnostics
12.4.5. HIV Diagnostics
12.4.6. Infectious Disease Diagnostics
12.4.7. Others Diagnostics
12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Antibody Type
12.6.2. By End-user
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Diagnostic Specialty Antibody Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Antibody Type, 2017–2027
13.2.1. Monoclonal Antibodies
13.2.2. Polyclonal Antibodies
13.2.3. Recombinant Polyclonal Antibodies
13.3. Market Value Forecast, by End-user, 2017–2027
13.3.1. Hospitals
13.3.2. Diagnostic Laboratories
13.3.3. Others
13.4. Market Value Forecast, by Application, 2017–2027
13.4.1. Hepatitis Diagnosis
13.4.2. Tuberculosis Diagnostics
13.4.3. Dengue Diagnostics
13.4.4. Oncology Diagnostics
13.4.5. HIV Diagnostics
13.4.6. Infectious Disease Diagnostics
13.4.7. Others Diagnostics
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Antibody Type
13.6.2. By End-user
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Diagnostic Specialty Antibody Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Antibody Type, 2017–2027
14.2.1. Monoclonal Antibodies
14.2.2. Polyclonal Antibodies
14.2.3. Recombinant Polyclonal Antibodies
14.3. Market Value Forecast, by End-user, 2017–2027
14.3.1. Hospitals
14.3.2. Diagnostic Laboratories
14.3.3. Others
14.4. Market Value Forecast, by Application, 2017–2027
14.4.1. Hepatitis Diagnosis
14.4.2. Tuberculosis Diagnostics
14.4.3. Dengue Diagnostics
14.4.4. Oncology Diagnostics
14.4.5. HIV Diagnostics
14.4.6. Infectious Disease Diagnostics
14.4.7. Others Diagnostics
14.5. Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Antibody Type
14.6.2. By End-user
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share/Position Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Abcam plc
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis
15.3.2. F. Hoffmann-La Roche Ltd.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Growth Strategies
15.3.2.3. SWOT Analysis
15.3.3. Abbott Laboratories
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis
15.3.4. Sanofi
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis
15.3.5. Bio-Rad Laboratories, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis
15.3.6. Boehringer Ingelheim International GmbH
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis
15.3.7. Agilent Technologies, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis
15.3.8. Aytu BioScience, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
List of Tables
Table 01: Pipeline Analysis of Diagnostic Specialty Antibody (1/2)
Table 02: Pipeline Analysis of Diagnostic Specialty Antibody (2/2)
Table 03: Global Diagnostic Specialty Antibody Market Size (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 04: Global Diagnostic Specialty Antibody Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 05: Global Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 09: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 10: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 11: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2027
Table 12: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 13: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 14: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 15: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/ Sub-Region, 2017–2027
Table 16: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 17: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 19: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 21: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 22: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 23: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Antibody Type, 2017–2027
Table 25 : Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 26: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global Diagnostic Specialty Antibody Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Market Snapshot of Global Diagnostic Specialty Antibody Market
Figure 03: Market Opportunity Map, Revenue Share, by Antibody Type
Figure 04: Market Opportunity Map, Revenue Share, by Application
Figure 05: Recent Key Industry Events of Diagnostic Specialty Antibody Market
Figure 06: Global Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast, 2017–2027
Figure 07: Market Value Share, by End-user, 2017
Figure 08: Market Value Share, by Antibody Type, 2017
Figure 09: Market Value Share, by Region, 2017
Figure 10: Market Value Share, by Application, 2017
Figure 11: Patent Filling Details of Various Diagnostic Antibody
Figure 12: Patent Filling Details of Various Diagnostic Antibody
Figure 13: Patent Filling Details of Various Diagnostic Antibody
Figure 14 : Global Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 15: Global Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 16: Global Monoclonal Antibodies Market Revenue
Figure 17: Global Polyclonal Antibodies Market Revenue
Figure 18: Global Recombinant Polyclonal Antibodies Market Revenue
Figure 19: Global Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 20: Global Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 21: Global Hepatitis Diagnostic Specialty Antibody Market Revenue
Figure 22: Global Tuberculosis Diagnostic Specialty Antibody Market Revenue
Figure 23: Global Dengue Diagnostic Specialty Antibody Market Revenue
Figure 24: Global Oncology Diagnostics Diagnostic Specialty Antibody Market Revenue
Figure 25: Global HIV Diagnostics Diagnostic Specialty Antibody Market Revenue
Figure 26: Global Infectious Disease Diagnostics Diagnostic Specialty Antibody Market Revenue
Figure 27: Global Other Diagnostics Diagnostic Specialty Antibody Market Revenue
Figure 28: Global Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 29: Global Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 30: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2027
Figure 31: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2017–2027
Figure 32: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 32: Global Diagnostic Specialty Antibody Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 33: Global Diagnostic Specialty Antibody Market Value Share, by Region, 2018 and 2027
Figure 34: Global Diagnostic Specialty Antibody Market Attractiveness, by Region, 2019–2027
Figure 35: North America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 36: North America Diagnostic Specialty Antibody Market Value Share, by Country, 2018 and 2027
Figure 37: North America Diagnostic Specialty Antibody Market Attractiveness, by Country, 2019–2027
Figure 38: North America Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 39: North America Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 40: North America Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 41: North America Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 42: North America Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 43: North America Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 44: Europe Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 45: Europe Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027
Figure 46: Europe Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 47: Europe Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 48: Europe Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 49: Europe Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 50: Europe Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 51: Europe Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 52: Europe Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 53: Asia Pacific Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 54: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027
Figure 55: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 56: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 57: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 58: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 59: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 60: Asia Pacific Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 61: Asia Pacific Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 62: Latin America Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 63: Latin America Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027
Figure 64: Latin America Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 65: Latin America Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 66: Latin America Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 67: Latin America Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 68: Latin America Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 69: Latin America Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 70: Latin America Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Figure 71: Middle East & Africa Diagnostic Specialty Antibody Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 72: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by Country/Sub-region, 2019–2027
Figure 73: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 74: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by Antibody Type, 2018 and 2027
Figure 75: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by Antibody Type, 2019–2027
Figure 76: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by Application, 2018 and 2027
Figure 77: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by Application, 2019–2027
Figure 78: Middle East & Africa Diagnostic Specialty Antibody Market Value Share, by End-user, 2018 and 2027
Figure 79: Middle East & Africa Diagnostic Specialty Antibody Market Attractiveness, by End-user, 2019–2027
Complete the form below and we'll get back to you shortly.